Kai Kliiman

Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study

Tracy Dalton, Peter Cegielski, Somsak Akksilp et al. · The Lancet · 2012 · 224 citations · Full text

Multidrug-resistant Tuberculosis, Pulmonary Tuberculosis, Preventive Medicine +12

European Union Standards for Tuberculosis Care

Giovanni Battista Migliori, Zellweger Jp, Ibrahim Abubakar et al. · European Respiratory Journal · 2012 · 208 citations · Full text

Tuberculosis Prevention, Preventive Medicine, Preventive Treatment +17

Clinical and operational value of the extensively drug-resistant tuberculosis definition

Giovanni Battista Migliori, Giorgio Besozzi, Enrico Girardi et al. · European Respiratory Journal · 2007 · 194 citations · Full text

Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies

Ekaterina V. Kurbatova, J. Peter Cegielski, Christian Lienhardt et al. · The Lancet Respiratory Medicine · 2015 · 156 citations · Full text

Multidrug-resistant Tuberculosis, Pulmonary Tuberculosis, Tuberculosis Prevention +8

Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study

Aditya Sharma, Andrew Hill, Ekaterina V. Kurbatova et al. · The Lancet Infectious Diseases · 2017 · 151 citations · Full text